NCT07048990

Brief Summary

This single-arm pilot study aims to explore the feasibility and acceptability of the culturally adapted, Ukrainian version of the Empowerment Group Therapy (Wiechers, 2023) manual and accompanying workbook for the Ukrainian population affected by the ongoing war. Feasibility will be evaluated based on participant retention. Acceptability will be assessed through questionnaires and qualitative feedback. The study also gathers preliminary data on the effectiveness of the intervention by assessing changes in quality of life, stress, symptoms of anxiety, depression, PTSD, and somatization. Overall, it seeks to explore the relevance and impact of group-based resilience therapy in a conflict-affected setting.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

June 18, 2025

Last Update Submit

June 30, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Feasibility of the intervention

    Feasibility will be indexed by inclusion rate of participants to the study.

    Post-Intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)

  • Feasibility of the intervention

    Feasibility will be indexed by participants attendance of the group therapy sessions (\>80% of sessions).

    Post-Intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)

  • Feasibility of the intervention

    Feasibility will be indexed by droup-out rate (\<20% of participants).

    Post-Intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)

  • Acceptability of the intervention

    Acceptability will be assessed by the rate of intervention completion (\>80% complete all sessions).

    Post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)

  • Acceptability of the intervention

    Acceptability will be assessed by using the Client Satisfaction Questionnaire (Attkisson \& Zwick, 1982).

    Post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)

Secondary Outcomes (6)

  • Stress, anxiety and depression

    At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)

  • Depressive symptoms

    At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)

  • PTSD Symptoms

    At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)

  • Somatic symptom burden

    At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)

  • Health-related Quality of Life

    At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)

  • +1 more secondary outcomes

Study Arms (1)

CBT-based group therapy intervention "Empowerment"

EXPERIMENTAL

10 CBT-based psychotherapeutic group sessions will be held weekly, either in person or online, through trained psychiatrists or psychotherapists from the Department of Medical Psychology, Psychosomatic Medicine, and Psychotherapy at Bogomolets National Medical University. During the first group session, participants will receive the workbook "Empowerment" ("Опора та стійкість"), which is to be completed at home between sessions as homework. Each session will include an assessment of the participants' general current condition, their engagement in the psychotherapeutic interventions, group dynamics, and more.

Behavioral: Empowerment Group Therapy

Interventions

Empowerment is a manualized, culturally sensitive treatment program. The treatment is based on a modular principle that transdiagnostically targets major symptom domains (e.g. stress, depression, anxiety), and can be flexibly adapted to individual mental health conditions of clients who participate in this program. The intervention is designed as a psychological group intervention for resource-limited settings and scalable for different formats (i.e. in-person, online, hybrid) to be feasible under the unstable conditions of war (e.g. missile attacks, power outrages). Key therapeutic elements are psychoeducation, emotion regulation strategies, problem solving and building coping skills. The activation of individual and culture-specific resources as well as building self-help skills are at focus of the treatment.

CBT-based group therapy intervention "Empowerment"

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Civilians
  • years of age or older
  • Residency in Ukraine at the onset of the full-scale war in Ukraine and at the time of the study
  • Ability to participate in in-person or online sessions
  • Ability to participate in online sessions, including communication via smartphone chat
  • Speaks Ukrainian or Russian
  • Presence of depression, anxiety, stress according to DSM-5 criteria, or psychological distress directly or indirectly caused by the war (other conditions may be included if deemed appropriate by a physician)
  • Moderate severity of symptoms on the depression, anxiety, or stress subscale of the DASS-21
  • Anyone who, upon being placed on the waiting list, recognizes a need for help and support is eligible to participate
  • Signed informed consent form

You may not qualify if:

  • Lack of informed consent
  • Diagnosis of schizophrenia, autism spectrum disorders, degenerative disorders, or significant cognitive impairments
  • Use of psychoactive substances and alcohol
  • Acute risk of suicide
  • Ongoing psychotherapy or psychotherapy within the past 3 months
  • Psychopharmacological treatment (at the discretion of the therapist during screening)
  • Current inpatient treatment
  • Incomplete screening questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Medical University Bogomolets

Kyiv, Kyiv Oblast, Ukraine

RECRUITING

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Central Study Contacts

Solveig Kemna, Dr. med.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident/research associate

Study Record Dates

First Submitted

June 18, 2025

First Posted

July 3, 2025

Study Start

November 5, 2024

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

July 3, 2025

Record last verified: 2025-06

Locations